Mild cognitive impairment (MCI) is a transitional state between normal cognitive functioning and dementia. A proposed MCI typology classifies individuals by the type and extent of cognitive impairment, yet few studies have characterized or compared these subtypes. Four hundred forty-seven women 65 years of age and older from the Women's Health Initiative Memory Study were classified into the 4 MCI subgroups and a ''no impairment'' group and compared on clinical, sociodemographic, and health variables. A cognitive deficit in at least 1 domain was present in 82.1% of participants, with most (74.3%) having deficits in multiple cognitive domains. Only 4.3% had an isolated memory deficit, whereas 21.3% had an isolated nonmemory deficit. Of the 112 women who met all MCI criteria examined, the most common subtype was amnestic multidomain MCI (42.8%), followed by nonamnestic multiple domain MCI (26.7%), nonamnestic single domain (24.1%), and amnestic single domain MCI (6.3%). Subtypes were similar with respect to education, health status, smoking, depression, and prestudy and onstudy use of hormone therapy. Despite the attention it receives in the literature, amnestic MCI is the least common type highlighting the importance of identifying and characterizing other nonamnestic and multidomain subtypes. Further research is needed on the epidemiology of MCI subtypes, clinical and biologic differences between them, and rates for conversion to dementia.
T he prevalence of age-associated cognitive decline and dementia is increasing in developed countries as the number of older adults rises. To improve identification and treatment of dementing diseases such as Alzheimer, attention to early detection and identification of predementia syndromes has intensified. Different definitions of milder forms of acquired cognitive loss in late life have been proposed including age-associated cognitive decline, 1 cognitive impairment-not dementia, 2 and mild cognitive impairment (MCI), 3 which has been the focus of much research.
MCI is considered a transitional state between normal, age-appropriate cognitive decline, and dementia. [4] [5] [6] The original Mayo MCI criteria are a subjective report of a memory problem, an objective memory performance deficit, preserved functioning in activities of daily living (ADL), generally normal global cognitive functioning, and no dementia. 3, [7] [8] [9] MCI so defined is associated with impaired learning and memory, 10 hippocampal atrophy, 11, 12 a greater than normal rate of cognitive decline, 3 death 13 and an increased risk of Alzheimer dementia (AD). 14 One limitation of the original Mayo MCI criteria is that they fail to describe nonmemory deficits or deficits occurring in multiple cognitive domains. Recently, a more comprehensive typology of MCI has been proposed that classifies individuals by the type or domain of their cognitive deficit (memory vs. nonmemory such as language, visuospatial, speed of processing, or executive function) and the extent of their deficits (single domain vs. multiple domains). Four MCI subtypes have been proposed: Amnestic MCI-Single Domain (a-MCI-sd), Nonamnestic MCI Single Domain (na-MCI-sd), Amnestic MCI-Multiple Domain (a-MCI-md), and Nonamnestic MCI-Multiple Domain (na-MCI-md). 4, 15, 16 However, there has been very limited research into the epidemiology of these subtypes in nonclinical populations and their clinical and demographic characteristics.
The Women's Health Initiative Memory Study 17 (WHIMS) is an ancillary study to the WHI Hormone Trial, a randomized, placebo-controlled, double-blind clinical trial of estrogen supplementation therapy, with or without a progestin. 18 WHIMS enrolled 7479 postmenopausal women who were 65 years of age or older. The primary outcome of WHIMS is adjudicated all-cause probable dementia (PD) with secondary endpoints of ''MCI'' and global cognitive function. At the time WHIMS began in 1996, the Mayo criteria were not available so a classification of ''MCI'' in WHIMS (WHIMS MCI) was applied by adjudicators to evident cognitive impairment that was less than levels considered to be indicative of PD and greater than normal aging. All WHIMS participants were screened annually for cognitive impairment with the Modified Mini Mental State (3MS) exam 19 and women who scored below the predesignated cut-point received a comprehensive clinical neuropsychiatric evaluation 17 and were classified as PD, WHIMS MCI, or No Impairment. The data from these evaluations are used here to algorithmically classify women into 1 of the 4 MCI subgroups or a No Impairment. Groups are then compared on sociodemographic, neurocognitive, and clinical variables including hormone therapy treatment assignment. Last, we compare our algorithmic classification with the clinical classification made in the main study.
METHODS

Participants
Eligible participants were 7479 postmenopausal women recruited into WHIMS from the 39 sites participating in the Women's Health Initiative Hormone Trials. 20 Four hundred eighty-three women received the comprehensive neuropsychiatric evaluation as described below. Thirty-six women did not provide supplemental data for adjudication: 33 refused further testing, 2 were too ill to return, and 1 died before testing could be conducted. A WHIMS adjudicated classification of either No Impairment or WHIMS MCI was assigned to 447 women. Probable dementia cases were excluded for this analysis. All women were between 65 and 79 years of age at enrollment.
Procedures
WHIMS Methodology
The WHIMS methodology has been described in detail elsewhere. 17, 21, 22 In brief, all WHIMS participants were administered the 3MS annually. Women scoring below preset standard cut points (r88 for Z9 y of education, r80 for r8 y) were given a complete neuropsychiatric evaluation that included the Consortium for the Establishment of a Registry for Alzheimer's Disease (CERAD) battery of neuropsychologic tests 23, 24 and standardized questions about acquired cognitive and functional impairments administered to participants and a knowledgeable friend or family member, [23] [24] [25] and a complete clinical evaluation by a broad certified dementia specialist (ie, neurologist, geropsychiatrist, or geriatrician) plus lab tests (computerized tomography of the brain without contrast and selected blood tests). The local dementia specialists then classified each woman into 1 of 3 groups: Probable Dementia based on criteria from the Diagnostic and Statistical Manual of the American Psychiatric Association-Third Edition, 26 WHIMS MCI or No Impairment. All data including the clinicians' classifications were then submitted to a centralized adjudication committee consisting of dementia experts at the WHIMS Coordinating Center at Wake Forest University School of Medicine for final classification (PD, WHIMS MCI, and No Impairment). Criteria for WHIMS MCI included cognitive deficits insufficient for a classification of PD, yet greater than expected for normal age-appropriate functioning.
Algorithmic Classification of MCI Subtypes
For this analysis, participants had to meet 4 MCI criteria identified by Winblad et al 4 : objective cognitive deficit(s), observed cognitive problems, the absence of an ADL impairment attributable to cognition, and no dementia. Evidence of cognitive deficits was defined as a score at or below the seventh percentile (1.5 standard deviation units below the mean) of age-matched and education-matched norms 27 on the CERAD subtests measuring episodic memory (Word List Delayed Recall or Constructional Praxis Recall), verbal fluency (Category Fluency-Animals), language (Boston Naming Test-15 item version), visuo-constructive skills (Constructional Praxis), speed of mental processing (Trail Making Test, Part A), and executive functioning (Trail Making Test, Part B). On the basis of their cognitive test scores, participants first were placed into 1 of 5 groups characterizing their cognitive deficits: amnestic single domain (a-sd); nonamnestic single domain (na-sd); amnestic multiple domains (a-md); nonamnestic multiple domains (na-md); and no cognitive deficits (No Deficit). For a-sd group, a deficit on at least 1 of the memory tests and no other test was required. For na-sd group, a deficit in verbal fluency, language, visuomotor skills, speed of mental processing, or executive function was required and no memory deficit. For a-md group, at least 1 deficit in memory plus at least 1 additional domain was required, and for na-md group deficits in 2 or more domains other than memory were required. Participants whose scores were all more than seventh percentile were classified as No Deficit.
Observed cognitive impairment was considered present, if the participant's friend or family member reported at least 1 of these problems during the preceding 6 months: ''difficulty remembering things that happened recently, in the past few hours or days;'' ''forgotten conversations that occurred a few hours or days earlier;'' ''asked the same questions repeatedly;'' ''forgotten to turn off the stove;'' and ''repeated herself more.'' Participants and proxies were independently asked 9 Yes/No questions about ADL deficits (bathing, grooming, feeding, dressing, preparing meals, simple household tasks, operating simple household appliances, shopping, handling money) occurring over the preceding 6-month period related to their cognitive functioning. We considered ADL impairment absent if both participant and her proxy agreed that these 9 functions were not impaired.
The MCI criterion that global cognitive functioning must be within the normal range was not applied in this analysis, as all women receiving a comprehensive evaluation in WHIMS had to have scored below the 3MS cutpoint for normal cognitive functioning.
Other Variables
Standardized questions were used to assess other demographic (age, education), medical (perceived health status, history of stroke, hypertension, or diabetes), and lifestyle variables (smoking, alcohol use) that could be related to cognitive function and pretrial use of hormone therapy and WHI HT treatment assignment (HT vs. No HT). The 15-item Geriatric Depression Scale-Short Form was administered to assess depressive symptom severity.
Analysis
Women were first grouped into 1 of 5 groups by the presence and type of a cognitive deficit: a-sd, na-sd, a-md, namd, and No Deficit. The other 2 criteria (observed cognitive problems, the absence of ADL impairments) are reported by cognitive deficit group. To evaluate the ability of observed cognitive problems to identify women with an underlying cognitive deficit, we calculated its sensitivity, specificity, and predictive power. The positive predictive power [PPP; (true positives/true positives+false positive) Â 100] is the probability that observed cognitive problems accompanies a cognitive deficit. Negative predictive power [NPP; (true negatives/true negatives+false negatives) Â 100] is the probability that the absence of observed cognitive problems is accompanied by the absence of a cognitive deficit. These indices could help clinicians decide how to weigh reports by family members regarding observed cognitive impairments. Women who met all 4 MCI criteria were grouped into 1 of 4 algorithmically defined MCI subtypes: aMCI-sd, naMCI-sd, aMCI-md, or naMCI-md. A comparison No Impairment group was formed of women with no cognitive deficits, no observed cognitive problems, and no ADL impairment. MCI subtypes were compared on demographic, health, lifestyle HT study group assignment, and cognitive tests scores using w 2 or Fisher Exact tests for categoric variables or Kruskall-Wallis tests for continuous variables. The significance level for pairwise comparisons, conducted with Wilcoxon tests when the overall P-value was <0.05, was 0.01 to adjust for multiple pairwise comparisons.
RESULTS
Sample Characteristics
The characteristics of the entire WHIMS sample have been described in detail elsewhere. 21, 22, 28 The subsample of 447 women with neurocognitive and clinical exam data have a mean age of 72.5 (4.0) year., is well-educated (51% had posthigh school education), and is in good health (83% rated their health as ''Good'', ''Very Good,'' or ''Excellent''). Two hundred thirty-five (53%) women of the WHIMS sample participated in the E-alone trial (54% in E-alone group, 46% placebo) and 212 women (47%) were in the E+P trial (52% in E+P group, 48% placebo).
Frequencies of Each MCI Criterion
All women were free of dementia meeting 1 of the MCI criteria. 4 Table 1 shows the frequencies of women meeting each of the other MCI criteria. Of 447 women, 82.1% had a cognitive deficit defined as scoring at or below the seventh percentile of the normative group on 1 or more of the neurocognitive tests. Of women with any cognitive deficit, 74.4% had deficits in multiple domains with more women (44.4%) having deficits that included memory than women with nonmemory deficits (30.0%). Only 4.4% of women with a deficit had an isolated memory deficit, whereas 21.3% had a single, nonmemory deficit. Almost one fifth of the women (17.9%) were without deficits despite having a positive screener score.
More women (58.4%) had cognitive problems that were observable by a close friend or family member than women who did not (41.6%; 38 of the 447 women with missing proxy data were excluded). Only 60.4% (203/336) of women with a cognitive deficit were also observed to have cognitive problems (sensitivity) and 50.7% (37/73) of women without cognitive deficits also were without cognitive problems (specificity). Having an observed cognitive problem was strongly predictive of underlying deficits: PPP = 84.9% (203/239) whereas not having an observed cognitive problem was a poor predictor of the absence of cognitive deficits: NPP = 21.8% (37/170). Two hundred ninety-seven women in the sample (73.7%) had no significant ADL impairments as required for a diagnosis of MCI whereas 106 (26.3%) had at least 1 reported by either the participants or a friend/family member (44 with missing ADL data were excluded). Normal ADL functioning was more common among women with a single cognitive deficit (a-sd = 86.7%, na-sd = 83.6%) than among women with multiple deficits (a-md = 66.2%, na-md = 70.2%). In the No (cognitive) Deficit group 80.3% had no ADL deficit. Women with memory deficits were about as likely to have normal ADL functioning as women with nonmemory cognitive deficits ( Table 1) .
Frequencies of Algorithmically-derived MCI Subtypes
Of the 447 women, 393 had complete data and could be classified into 1 of the 4 MCI groups or the No Impairment group based on the cognitive deficit (Table 1) . One hundred twelve women (28.5%) met all 4 MCI criteria and were classified into 1 of the 4 MCI groups and 32 women (8.1%) met none of the criteria and were classified as No Impairment. Of the 112 algorithmical defined MCI cases 7 women (6.3%) met criteria for the aMCI-sd subtype, 27 (24.1%) met criteria for the naMCI-sd subtype, 48 (42.9%) were classified as the aMCI-md subtype, and 30 (26.8%) met criteria for the naMCI-md subtype. Thus, the proportions of women meeting criteria for each MCI subtype from the full WHIMS subsample of 393 were 1.8%, 6.9%, 12.2%, and 7.6%, respectively.
Agreement Between Clinicians and Algorithm
The overall agreement between WHIMS clinicians' classification of WHIMS MCI and the algorithm-derived classification ( Table 3 shows scores on the neurocognitive measures at the index visit by MCI subtype. As classification into MCI subgroups depended in part on scores on these tests, it was expected that there would be group differences and that the No Impairment group would outperform the MCI groups. Women in the multidomains MCI groups had significantly poorer performance (P<0.01) than women with no impairment for all tests except for the Word List Delayed Recall in which there were no differences between the No Impairment and the na-MCI-md group. When compared with the No Impairment group, women in the a-MCI-sd group had significantly poorer performance (P<0.01) on recall tasks (Word List Delayed Recall, Constructional Praxis Recall) whereas those with singular, nonamnestic deficits scored significantly worse (P<0.01) on the Boston Naming and Trail Making Tests. Women in the a-MCI-md carried out significantly worse than those in the na-MCI-md on the Word List Delayed Recall, Constructional Praxis Recall tests and better on the Boston Naming test (P<0.01). The scores on the WHIMS screening measure (3MS) at the index visit were not different across all groups perhaps because it was the criterion test for inclusion so thus it had a limited distribution. variables. Significant group differences were found for age at randomization (P<0.0001) and age at the index visit (P = 0.0002)-women in the a-MCI-md group were slightly younger than women in all other groups (P<0.01). A greater proportion of women in the MCI single domain subgroups drank alcohol (Z1 drink/d) than women in the multidomain MCI subgroups and No Impairment group (P = 0.01). There were no significant group differences for depressive symptoms; self-reported health status; incidence of cerebrovascular events, hypertension or diabetes; frequency of smokers, or either pretrial or on-trial HT exposure (all P>0.05).
Neurocognitive Measures at the Index Visit
Demographic and Clinical Characteristics of the MCI Subtypes
DISCUSSION
The recent development of a 4-group MCI typology that includes amnestic and nonamnestic and single and multiple domain subtypes highlights the need for epidemiologic, clinical, and biologic studies to characterize each subtype. This study examined the prevalence of each subtype in a sample of older women participating in a clinical trial of hormone therapy using criteria proposed by Winblad et al 4 and compared them on demographic and clinical variables. In this sample of older women preselected on the basis of a 3MS score below study cut-point, 4 of every 5 women had at least 1 cognitive deficit measured by more sensitive cognitive tests, with three quarters having deficits in multiple cognitive domains. Just over half of the sample had observable cognitive problems whereas over two thirds were free of ADL impairments. Of the women with cognitive deficits, 30.5% (112/367) met all 3 criteria and were classified into 1 of the MCI subgroups, whereas 8% of the sample met none of the criteria.
Despite its prominence in the MCI literature, the aMCI-sd subtype represented only 6% of the algorithm defined MCI cases. This proportion is similar to estimates from other community-based samples that range between 0.05% and 6%. [29] [30] [31] [32] Estimates may vary across studies because of differences in samples, measures, cut-points, criteria, or whether single and multiple domain amnestic groups are combined; however, prevalence estimates for the aMCI-sd subtype are consistently low. Thus, our data also reveal that most women with MCI do not meet criteria for pure amnestic MCI highlighting the importance of better characterizing other MCI subtypes and supporting the development of a multigroup MCI typology. Amnestic, multidomain MCI was the most prevalent of all 4 subtypes accounting for 43% of cases. Although the number of cases is too small for subanalyses, this subtype may offer an opportunity to pair specific cognitive deficits with underlying neuropathologies. For example, APOE epsilon4 genotype was associated only with amnestic MCI and with impaired memory function. 33 In addition, Jicha et al 34 recently reported that MCI associated with Lewy body dementia (MCI-LBD) shows a different pattern of cognitive deficits than MCI associated with Alzheimer dementia (MCI-AD). Scores on a letter fluency task were poorer and scores on a memory task were higher in the MCI-LBD group compared with the MCI-AD.
Forty-nine percent of the women in our sample had memory deficits and over half had deficits in multiple domains rather than a single domain. Lopez et al 35 reported almost 3 times as many multidomain MCI cases compared with a-MCI-sd cases in the Cardiovascular Health Study Cognition Study. As we did, Manly et al found a larger proportion of nonamnestic MCI (17%) compared with amnestic MCI (11%) and in particular to single domain amnestic MCI (5%). In contrast, Busse et al 36 reported that single domain subtypes were more frequent than multiple domain subtypes in their community-based sample and the prevalence of amnestic and nonamnestic subtypes did not differ. Taken together, these studies show that multiple domain MCIs seem more prevalent than single domain MCI subtypes. Given the greater emphasis in the clinical literature on the aMCI-sd subtype, multidomain, and nonamnestic single domain subtypes may be under detected and under studied. Although 82% of our sample had cognitive deficits, only 60% had cognitive problems significant enough to be observed by a friend or family member. This cannot be explained by demographic or clinical variables or exposure to HT. It suggests that these women are using a variety of cognitive, behavioral, environmental, or social resources to prevent cognitive deficits from becoming cognitive impairments. Some have argued that individuals who are able to use a wider range of neural networks and cognitive processes possess greater cognitive reserve (CR) which may explain why some individuals are able to maintain cognitive function despite having neuropathologies such has Alzheimer disease. [37] [38] [39] [40] Educational attainment, a common proxy for CR, was relatively high in our sample which suggests that CR may explain why some women showed no functional problems despite having cognitive deficits.
Some have argued that the inclusion of subjective reports of cognitive problems are unnecessary for identifying MCI in population-based samples, 29 but our data suggest that it may be helpful. A high proportion (82%) of women with observed cognitive problems also had an underlying cognitive deficit. Among older postmenopausal women with some mild, global cognitive deficits (lower 3MS score) observed cognitive problems help to identify those who need a thorough clinical evaluation.
Minimal or no ADL impairments are required for a diagnosis of MCI. As most (72%) women met this criterion, it is a weaker discriminator than cognitive problems perhaps because ADLS are routine and therefore, less subject to interference than more novel tasks. Nevertheless, ADL problems were more common among women with more pronounced cognitive deficits, whereas the type of cognitive deficit was not associated with differential ADL impairments. This implies that a heavier overall cognitive deficit load may be more critical to ADL functioning, perhaps because ADL functioning depends on a variety of cognitive abilities.
There was moderately good agreement (69%) between clinicians and the MCI algorithm. It was not surprising that there were fewer algorithm determined cases of MCI than there were clinically determined cases because the latter relied on additional sources of information and used less stringent criteria more closely resembling the cognitive impairment-not dementia classification 2 than current MCI criteria. 4 Moreover, almost all of the disagreements indicated a more lenient or less severe classification by clinicians, which is in line with the more lenient WHIMS MCI criteria. The nature of the disagreements points to the significance of applying differing MCI criteria and supports efforts to refine and define MCI syndromes. Future studies will examine the comparative rates of cognitive decline and progression to dementia.
The 3MS showed very good sensitivity for identifying women with cognitive deficits documented by our neurocognitive battery-82% of WHIMS participants with a 3MS score below the cut-point had cognitive deficits in single or multiple domains based on the more sensitive measures found in the CERAD neurocognitive battery. However, it did not distinguish between the 4 MCI subtypes, thus supporting its use only for screening but not as a diagnostic tool. In addition, given the high level of education in our sample, which may reflect greater cognitive reserve, there is a likelihood that the 3MS failed to identify preclinical cases of dementia-women with underlying AD or other neuropathologies, but who do not manifest cognitive deficits sufficient to be adjudicated PD or MCI (ie, false negatives).
The primary outcome in WHIMS was incident dementia associated with HT versus placebo. In our original report we found a nonsignificant treatment effect for WHIMS MCI, although there was a significant adverse effect on incident PD. Similarly in this analysis, we did not find an association between HT and algorithm-defined MCI. This suggests that HT in postmenopausal women may exert its greatest adverse effect on women with more advanced underlying neuropathology than MCI. The significant group differences for age and alcohol consumption are based on small cell sizes and are therefore, difficult to interpret.
This study has several limitations. WHIMS included women participating in a clinical trial, thus, the generalizability of these results is uncertain. Our findings may be limited to women with characteristics similar to those in our sample. As noted, in WHIMS only women who score below the 3MS cut-point received a full neurocognitive evaluation. Thus, the MCI criteria used in this analysis are different from conventional criteria. 4, 16 It is noteworthy that at least 1 other study used modified criteria similar to ours and reported similar findings. 9 Nevertheless, this may explain why such a high proportion of women (82%) in this sample had specific cognitive deficits. In addition, we relied on norms for the CERAD test battery derived from a population (ie, Cache County, Utah residents) of unknown comparability with the WHIMS sample. However to guard against overestimates of MCI subtypes, we chose conservative cut-points for cognitive tests (rseventh percentile). Strengths of the study include the use of a standardized and validated neurocognitive battery and clinical procedures, a large sample of postmenopausal women who are geographically diverse, and a prospective study design.
This study examined the cognitive and behavioral deficits of a sample of nondemented, postmenopausal women who were classified into 1 of 4 MCI subgroups or a no impairment group according to newly proposed criteria. This is one of the earliest and few studies to characterize the 4-group MCI typology. We documented that among women prescreened for mild global cognitive deficits, most had clinically meaningful deficits when assessed with sensitive, domain-specific neurocognitive tests, and that the deficits most often involved multiple cognitive domains. Consistent with other studies, we identified only a relatively small proportion of women with the pure amnestic MCI syndrome highlighting the importance of more research into nonmemory and multidomain MCI subtypes. Future studies are needed to identify clinical and biologic characteristics that distinguish subtypes, to define the epidemiology of MCI in populations of interest, and to estimate the rate of conversion to dementia.
